» Articles » PMID: 35323860

MutateX: an Automated Pipeline for in Silico Saturation Mutagenesis of Protein Structures and Structural Ensembles

Overview
Journal Brief Bioinform
Specialty Biology
Date 2022 Mar 24
PMID 35323860
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations, which result in amino acid substitutions, influence the stability of proteins and their binding to biomolecules. A molecular understanding of the effects of protein mutations is both of biotechnological and medical relevance. Empirical free energy functions that quickly estimate the free energy change upon mutation (ΔΔG) can be exploited for systematic screenings of proteins and protein complexes. In silico saturation mutagenesis can guide the design of new experiments or rationalize the consequences of known mutations. Often software such as FoldX, while fast and reliable, lack the necessary automation features to apply them in a high-throughput manner. We introduce MutateX, a software to automate the prediction of ΔΔGs associated with the systematic mutation of each residue within a protein, or protein complex to all other possible residue types, using the FoldX energy function. MutateX also supports ΔΔG calculations over protein ensembles, upon post-translational modifications and in multimeric assemblies. At the heart of MutateX lies an automated pipeline engine that handles input preparation, parallelization and outputs publication-ready figures. We illustrate the MutateX protocol applied to different case studies. The results of the high-throughput scan provided by our tools can help in different applications, such as the analysis of disease-associated mutations, to complement experimental deep mutational scans, or assist the design of variants for industrial applications. MutateX is a collection of Python tools that relies on open-source libraries. It is available free of charge under the GNU General Public License from https://github.com/ELELAB/mutatex.

Citing Articles

Point mutations of the mitochondrial chaperone TRAP1 affect its functions and pro-neoplastic activity.

Laquatra C, Magro A, Guarra F, Lambrughi M, Ferrone L, Fracasso G Cell Death Dis. 2025; 16(1):172.

PMID: 40074754 PMC: 11903959. DOI: 10.1038/s41419-025-07467-6.


Saturation genome editing-based clinical classification of BRCA2 variants.

Sahu S, Galloux M, Southon E, Caylor D, Sullivan T, Arnaudi M Nature. 2025; 638(8050):538-545.

PMID: 39779848 DOI: 10.1038/s41586-024-08349-1.


Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activity.

Kwon J, Dilly J, Liu S, Kim E, Bian Y, Dharmaiah S bioRxiv. 2024; .

PMID: 39484452 PMC: 11526993. DOI: 10.1101/2024.10.22.618529.


Most azole resistance mutations in the Candida albicans drug target confer cross-resistance without intrinsic fitness cost.

Bedard C, Gagnon-Arsenault I, Boisvert J, Plante S, Dube A, Pageau A Nat Microbiol. 2024; 9(11):3025-3040.

PMID: 39379635 DOI: 10.1038/s41564-024-01819-2.


Genomics 2 Proteins portal: a resource and discovery tool for linking genetic screening outputs to protein sequences and structures.

Kwon S, Safer J, Nguyen D, Hoksza D, May P, Arbesfeld J Nat Methods. 2024; 21(10):1947-1957.

PMID: 39294369 PMC: 11466821. DOI: 10.1038/s41592-024-02409-0.